Cargando…

Catecholamine index is a simple and useful marker for bacteremic patients treated by polymyxin B hemoperfusion therapy

Detalles Bibliográficos
Autores principales:	Isa, Y, Harayama, N, Arai, H, Shinjou, T, Nagata, K, Ueki, M, Nihei, S, Aibara, K, Kamochi, M
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3061749/ http://dx.doi.org/10.1186/cc9539

Ejemplares similares

Comparison of nifekalant and amiodarone for resuscitation after cardiopulmonary arrest due to shock-resistant ventricular fibrillation
por: Harayama, N, et al.
Publicado: (2011)

Bacteremia affects the mortality of septic patients with high serum procalcitonin level in the ICU
por: Kamochi, M, et al.
Publicado: (2012)

Comparison of nifekalant and amiodarone for resuscitation of out-of-hospital cardiopulmonary arrest resulting from shock-resistant ventricular fibrillation
por: Harayama, Nobuya, et al.
Publicado: (2014)

Polymyxin B hemoperfusion: a mechanistic perspective
por: Ronco, Claudio, et al.
Publicado: (2014)

Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors
por: Cantaluppi, Vincenzo, et al.
Publicado: (2008)

More effective use of polymyxin-B hemoperfusion for nonoperation cases
por: Yahata, M, et al.
Publicado: (2014)

Polymyxin B-immobilized fiber hemoperfusion therapy improves sepsis-related immunosuppression
por: Kimura, A, et al.
Publicado: (2014)

Effective use of polymyxin B hemoperfusion in septic shock complicated by urosepsis
por: Malleshappa, P., et al.
Publicado: (2011)

Polymyxin B-direct hemoperfusion therapy contributes to oxygen delivery in septic patients
por: Yaguchi, A, et al.
Publicado: (2012)

Polymyxin-B hemoperfusion in septic patients: analysis of a multicenter registry
por: Cutuli, Salvatore Lucio, et al.
Publicado: (2016)

Changes in Oxygenation and Serological Markers in Acute Exacerbation of Interstitial Lung Disease Treated with Polymyxin B Hemoperfusion
por: Lee, Song-I, et al.
Publicado: (2022)

Beneficial effects of early hemoperfusion with a polymyxin B fibre column on septic shock
por: Takeyama, N, et al.
Publicado: (2009)

Polymyxin B hemoperfusion in high endotoxin activity level septic shock patients
por: Monti, G, et al.
Publicado: (2008)

Oxygen metabolism as an indicator in criteria for hemoperfusion using a polymyxin-B immobilized column introduction
por: Kushi, H, et al.
Publicado: (2005)

Efficacy of polymyxin B hemoperfusion in and beyond septic shock: is an “endotoxin severity score” needed?
por: Honore, Patrick M., et al.
Publicado: (2018)

Procalcitonin level as a marker of severe sepsis and septic shock patients who required polymyxin-B immobilized fiber with direct hemoperfusion
por: Ikeda, T, et al.
Publicado: (2012)

Polymyxin B-direct hemoperfusion therapy could contribute to hemodynamics and outcomes in emergency surgical patients
por: Yokota, M, et al.
Publicado: (2012)

Hemoperfusion with an immobilized polymyxin B fiber column improves gastric mucosal pH with sepsis patients
por: Kushi, H, et al.
Publicado: (2006)

Polymyxin B-direct hemoperfusion therapy improves mean arterial pressure in septic shock
por: Yokota, Mari, et al.
Publicado: (2013)

Efficacy of direct hemoperfusion with a polymyxin B‐immobilized fiber column in miliary tuberculosis
por: Kawano, Yasumasa, et al.
Publicado: (2016)

Regional citrate-calcium anticoagulation during polymyxin-B hemoperfusion: A case series
por: Forfori, Francesco, et al.
Publicado: (2018)

Effectiveness of polymyxin B hemoperfusion in acute exacerbation of interstitial pneumonia: a retrospective analysis
por: Lee, Song-I
Publicado: (2021)

Direct hemoperfusion using a polymyxin B‐immobilized polystyrene column for COVID‐19
por: Katagiri, Daisuke, et al.
Publicado: (2020)

Polymyxin B Hemoperfusion in Pediatric Septic Shock: Single-Center Observational Case Series
por: Saetang, Patcharin, et al.
Publicado: (2022)

Endotoxin activity assay and polymyxin B hemoperfusion use in a cohort of critically ill patients
por: Cutuli, SL, et al.
Publicado: (2014)

Early introduction of hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation
por: Kushi, H, et al.
Publicado: (2005)

Re-evaluation of direct hemoperfusion with polymyxin-B immobilized fiber for severe sepsis and septic shock
por: Matsuo, SM, et al.
Publicado: (2011)

The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis patients
por: Srisawat, Nattachai, et al.
Publicado: (2018)

Suggestions and tips regarding polymyxin B-immobilized fiber column direct hemoperfusion of neonates with sepsis
por: Nishizaki, Naoto
Publicado: (2020)

The golden hour of polymyxin B hemoperfusion in endotoxic shock: The basis for sequential extracorporeal therapy in sepsis
por: De Rosa, Silvia, et al.
Publicado: (2019)

Polymyxin B hemoperfusion as a feasible therapy after source control in abdominal septic shock
por: Kim, Jin Joo, et al.
Publicado: (2019)

Up-to-date information on polymyxin B-immobilized fiber column direct hemoperfusion for septic shock
por: Mitaka, Chieko, et al.
Publicado: (2021)

Polymyxin B-immobilized fiber column hemoperfusion has the ability of endotoxin removal during 24 hours
por: Mitaka, C, et al.
Publicado: (2012)

Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation
por: Kushi, Hidehiko, et al.
Publicado: (2005)

Impact of hemoperfusion with polymyxin B added to hemofiltration in patients with endotoxic shock: a case–control study
por: Navas, Ana, et al.
Publicado: (2018)

Effectiveness of polymyxin B hemoperfusion for sepsis depends on the baseline SOFA score: a nationwide observational study
por: Fujimori, Kenji, et al.
Publicado: (2021)

The effects of direct hemoperfusion with polymyxin B-immobilized fiber in patients with acute exacerbation of interstitial lung disease
por: Lee, Jae Ha, et al.
Publicado: (2021)

Modifications of peripheral perfusion in patients with vasopressor-dependent septic shock treated with polymyxin B-direct hemoperfusion
por: Sekino, Motohiro, et al.
Publicado: (2023)

278. Effects of polymyxin B direct hemoperfusion by measurement of outer membrane vesicles in patients with septic shock
por: Min Jo, Kyeong
Publicado: (2023)

Initial central venous pressure could be a prognostic marker for hemodynamic improvement of polymyxin B direct hemoperfusion: a retrospective cohort study
por: Yamada, Hiroyuki, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1gqchhh3dfqdbu445696tc53jk